tradingkey.logo

Unicycive Therapeutics - Crl Cites Deficiencies At Third-Party Manufacturing Vendor Unrelated To Olc

ReutersJun 30, 2025 11:26 AM

- Unicycive Therapeutics Inc UNCY.O:

  • UNICYCIVE THERAPEUTICS ANNOUNCES RECEIPT OF COMPLETE RESPONSE LETTER FOR OXYLANTHANUM CARBONATE FOR THE TREATMENT OF HYPERPHOSPHATEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE ON DIALYSIS

  • UNICYCIVE THERAPEUTICS INC - CRL CITES DEFICIENCIES AT THIRD-PARTY MANUFACTURING VENDOR UNRELATED TO OLC

  • UNICYCIVE THERAPEUTICS INC - TO REQUEST TYPE A MEETING WITH FDA TO ALIGN ON NEXT STEPS

  • UNICYCIVE THERAPEUTICS INC - SECOND MANUFACTURING VENDOR IDENTIFIED TO RESOLVE CMC ISSUES IN CRL

  • UNICYCIVE THERAPEUTICS INC - NO OTHER CONCERNS STATED IN CRL, INCLUDING PRE-CLINICAL, CLINICAL, OR SAFETY DATA

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI